Immunohistochemical Biomarker Validation Protocol
Corresponding Organization :
Other organizations : Queen's University Belfast, Belfast Health and Social Care Trust
Protocol cited in 270 other protocols
Variable analysis
- Biomarker conditions (CD3, CD8, p53, PD-L1)
- Measured outcomes of biomarker expression
- IHC was performed in a hybrid laboratory with UK Clinical Pathology Accreditation
- Biomarker conditions followed UK-NEQAS guidelines (CD3 and CD8) or were based on expected performance from the literature (p53 and PD-L1)
- Positive controls: Not explicitly mentioned
- Negative controls: Not explicitly mentioned
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!